| Detected | Trial | Change |
|---|---|---|
| 2026-06-02 | NCT07509151 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia… |
Recruitment opened |
| 2026-06-02 | NCT07509151 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia… |
Trial sites expanded: 13 -> 30 locations |
| 2026-06-02 | NCT07509151 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia… |
date change Primary completion moved earlier: 2032-11-29 -> 2031-08-29 |
| 2026-06-02 | NCT07509151 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia… |
date change Completion moved earlier: 2033-08-29 -> 2032-04-05 |
| 2026-05-28 | NCT06137118 AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia |
Enrollment increased: 163 -> 236 participants |
| 2026-05-21 | NCT06549595 A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular… |
Trial sites expanded: 159 -> 193 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06549595 | A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular… | Untreated Follicular Lymphoma | Recruiting |
| NCT07215585 | AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL | Large B-cell Lymphoma | Recruiting |
| NCT07509151 | Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia… | Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV | Recruiting |
| Phase 2 | |||
| NCT06526793 | Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R)… | B-cell Non-Hodgkin Lymphoma | Recruiting |
| NCT07571746 | A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated… | Primary Membranous Nephropathy | Recruiting |
| Phase 1/2 | |||
| NCT06137118 | AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | B-cell Acute Lymphoblastic Leukemia (B-ALL) | Recruiting |
| NCT06564038 | A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature… | Chronic Lymphocytic Leukaemia | Recruiting |
| Phase 1 | |||
| NCT07201558 | Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE… | Rheumatoid Arthritis | Recruiting |
| NCT04594642 | A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma | B-cell Non Hodgkin Lymphoma | Recruiting |